Live Updates > Live Update Details
2025-07-31 08:10:11
[Li Tao, Deputy Director of the National Healthcare Security Administration, meets with the Government of Singapore Investment Corporation] According to the National Healthcare Security Administration, on July 28, Li Tao, Deputy Director of the National Healthcare Security Administration, met with the Government of Singapore Investment Corporation (GIC) in Beijing. The two sides had in-depth exchanges on the support of medical insurance for the development of innovative drugs. Li Tao said that in the next step, the National Healthcare Security Administration will continue to implement relevant policy measures and increase its openness to help the development of medical institutions, medical technology progress, drug innovation and improvement, and industrial transformation and upgrading. Domestic and foreign investment institutions are welcome to pay attention to China's innovative drugs, invest in China's innovative drugs, pay attention to health, and invest in health. The Singapore Government Investment Corporation stated that the international competitiveness of China's innovative drug companies is increasing, and the policy signals of China's National Healthcare Security Administration and other government departments to support the high-quality development of innovative drugs are clear and unambiguous. The market has good expectations for the development of China's innovative drug industry. It is hoped that communication and exchanges with China's National Healthcare Security Administration and other departments will continue to be strengthened in the future.
